Heart attack and stroke, a leading cause of death in the United States, have been associated with blood platelet aggregation. Onion extract inhibits blood platelet aggregation both in vitro and in vivo. Current trends toward natural foods and health remedies may point to the importance of onion-induced antiplatelet activity (OIAA). The genetic control of OIAA has yet to be revealed. One-hundred-eighty-three F3 families were derived from a long-day mild inbred line crossed to a long-day pungent inbred line that differ by for OIAA by 67%. Families were grown in a RCB design with two replications in muck soil (Randolph, Wis.) in 1997. Extracts were made from crushing bulb tissue in a mechanical juicer. F3 families were evaluated for OIAA and soluble solids (SS). OIAA was measured by electrical impedance aggregometry using two human blood donors. Endpoint (ohms) and slope of the aggregation curve were recorded. SS were measured by refractometry. F3 families were significantly different for OIAA and SS (P < 0.0001) in the ANOVA. A strong positive correlation of 0.96 was revealed for slope of curve and endpoint across families, replications, and blood donors. This correlation has not been previously reported for onion and suggests that for these families, descriptions of OIAA based on either rate of aggregation or endpoint are functionally equivalent. Both SS and OIAA exhibit transgressive segregation in this group of F3 families. Twenty percent exhibit OIAA stronger than the pungent parent and 5% were less than the mild parent. The family with the highest OIAA was 4-fold higher than the pungent parent of the cross, which could be useful in future onion breeding efforts. In addition, transgressive segregation in these families aids in QTL investigations for OIAA, SS and other economically important traits.